NDC 0591-5716

Amoxapine

Amoxapine

Amoxapine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Amoxapine.

Product ID0591-5716_2271a75a-f4d1-4ed9-8d66-092721bcdb2e
NDC0591-5716
Product TypeHuman Prescription Drug
Proprietary NameAmoxapine
Generic NameAmoxapine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1992-08-28
Marketing CategoryANDA / ANDA
Application NumberANDA072691
Labeler NameActavis Pharma, Inc.
Substance NameAMOXAPINE
Active Ingredient Strength150 mg/1
Pharm ClassesTricyclic Antidepressant [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0591-5716-30

30 TABLET in 1 BOTTLE, PLASTIC (0591-5716-30)
Marketing Start Date1992-08-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0591-5716-30 [00591571630]

Amoxapine TABLET
Marketing CategoryANDA
Application NumberANDA072691
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1992-08-28

Drug Details

Active Ingredients

IngredientStrength
AMOXAPINE150 mg/1

OpenFDA Data

SPL SET ID:a16297df-3158-48db-85e5-5cd506885556
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197364
  • 197365
  • 197366
  • 197363
  • UPC Code
  • 0305915715019
  • Pharmacological Class

    • Tricyclic Antidepressant [EPC]
    • Tricyclic Antidepressant [EPC]

    NDC Crossover Matching brand name "Amoxapine" or generic name "Amoxapine"

    NDCBrand NameGeneric Name
    0591-5713AmoxapineAmoxapine
    0591-5714AmoxapineAmoxapine
    0591-5715AmoxapineAmoxapine
    0591-5716AmoxapineAmoxapine

    © 2026 FDA.report
    This site is not affiliated with or endorsed by the FDA.